These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3161707)

  • 1. Reversal of left ventricular hypertrophy by drug treatment of hypertension.
    Schlant RC
    Chest; 1985 Sep; 88(3 Suppl):194S-196S, 198S. PubMed ID: 3161707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of left ventricular hypertrophy in hypertension with alpha-adrenergic blockade: physiological basis and therapeutic implications.
    Ram CV
    J Hypertens Suppl; 1989 Dec; 7(6):S98-9. PubMed ID: 2576672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic documentation of regression of left ventricular hypertrophy in patients treated for essential hypertension.
    Schlant RC; Felner JM; Blumenstein BA; Wollam GL; Hall WD; Shulman NB; Heymsfield SB; Gilbert CA; Tuttle EP
    Eur Heart J; 1982 Apr; 3 Suppl A():171-5. PubMed ID: 6210543
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antihypertensive treatment and remission of left ventricular hypertrophy. Critical study].
    Clémenty J; Dulhoste MN; Bordier P; Lartigue MC; Pons N
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():39-43. PubMed ID: 2150473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian blood pressure pattern in patients with treated hypertension and left ventricular hypertrophy.
    Klein W; Zweiker R; Eber B; Dusleag J; Brussee H; Rotman B
    Angiology; 1991 May; 42(5):379-86. PubMed ID: 1827968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.
    Idikio H; Fernandez PG; Triggle CR; Kim BK
    Clin Invest Med; 1983; 6(1):43-8. PubMed ID: 6219850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of left ventricular mass in systemic hypertension.
    Georgiou D; Brundage BH
    Clin Cardiol; 1992 Jan; 15(1):5-16. PubMed ID: 1531790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and regression of left ventricular hypertrophy.
    Panidis IP; Kotler MN; Ren JF; Mintz GS; Ross J; Kalman P
    J Am Coll Cardiol; 1984 May; 3(5):1309-20. PubMed ID: 6231335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of left ventricular hypertrophy: a desirable therapeutic goal?
    Schmieder RE; Messerli FH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S16-22. PubMed ID: 1707110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart and vessel hypertrophy in hypertension: possibilities of regression.
    Cífková R; Niederle P; Romanovská L; Skibová J; Frídl P; Skalická H; Widimský J
    J Hypertens Suppl; 1987 Dec; 5(5):S407-10. PubMed ID: 2965227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of reversal of hypertensive cardiac hypertrophy by captopril on left ventricular pumping ability and performance.
    Saragoça MA; Cezaretti ML; Bessa AM; Casarini D; Almeida JB; Amorim MP; Ramos OL
    J Hypertens Suppl; 1987 Dec; 5(5):S403-6. PubMed ID: 2965226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of left ventricular hypertrophy by medical treatment: present status and possible implications.
    Tarazi RC
    Am J Med; 1983 Sep; 75(3A):80-6. PubMed ID: 6226199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term effects of indapamide in left ventricular hypertrophy in patients with hypertension].
    Komajda M; Klimczak K; Evans J; Boutin B; Brackman F; Guez D; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():45-50. PubMed ID: 2150474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertensive cardiopathy. Functional evaluation during isometric effort after regression of left ventricular hypertrophy].
    Nogueira JB; Freitas A; Morais C; Silva D; Esteves J; da Costa JN
    Rev Port Cardiol; 1992 Mar; 11(3):229-38. PubMed ID: 1535203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition, cell growth, and left ventricular hypertrophy in hypertension.
    Giles TD
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV63-7; discussion IV83-90. PubMed ID: 1832601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of left ventricular hypertrophy following treatment with beta-blockers: experience with tertatolol.
    Trimarco B; Ricciardelli B; de Luca N; Cuocolo A; Volpe M; Lembo G; Condorelli M
    Am J Nephrol; 1986; 6 Suppl 2():94-9. PubMed ID: 2879479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of a 2-year examination of patients with essential hypertension and left ventricular hypertrophy].
    Cifková R; Niederle P; Fridl P; Skalická G; Skibová E
    Kardiologiia; 1988 Jan; 28(1):27-30. PubMed ID: 2965771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for cardiac involvement in essential hypertension.
    Zahka KG
    Cardiol Clin; 1986 Feb; 4(1):81-93. PubMed ID: 2939953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertensive hypertrophy of the left ventricle: its regression in hypertensive patients with different profiles of plasma renin activity, treated with enalapril].
    Nogueira JB; Soares Ade O; da Costa JN
    Rev Port Cardiol; 1990 Jun; 9(6):511-6. PubMed ID: 2147377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ACE inhibition: mechanisms of cardioprotection in heart hypertrophy].
    Motz W; Strauer BE
    Klin Wochenschr; 1991; 69 Suppl 24():39-43; discussion 43-4. PubMed ID: 1830911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.